Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Pulmonary hypertension complicating fibrosing mediastinitis

Andrei Seferian, Alexandru Steriade, Xavier Jaïs, Olivier Planché, Laurent Savale, Florence Parent, David Amar, Roland Jovan, Elie Fadel, Olivier Sitbon, Gérald Simonneau, Marc Humbert, David Montani
European Respiratory Journal 2016 48: OA261; DOI: 10.1183/13993003.congress-2016.OA261
Andrei Seferian
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandru Steriade
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xavier Jaïs
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Planché
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
4Service de Radiologie, AP-HP, Hôpital Bicêtre, Le Kremlin-Bicêtre, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laurent Savale
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Florence Parent
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Amar
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland Jovan
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elie Fadel
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
5Service de Chirurgie thoracique, Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Olivier Sitbon
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gérald Simonneau
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marc Humbert
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Montani
1Faculté de Médecine, Université Paris Sud, Le Kremlin-Bicêtre, France
2Service de Pneumologie, AP-HP, Centre de Référence de l'Hypertension Pulmonaire Sévère, Département Hospitalo-Universitaire (DHU) Thorax Innovation (TORINO), Hôpital Bicêtre, Le Kremlin-Bicêtre, France
3UMR_S Inserm 999, Laboratoire d'Excellence (LabEx) en Recherche sur le Médicament et l'Innovation Thérapeutique (LERMIT), Centre Chirurgical Marie Lannelongue, Le Plessis-Robinson, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Fibrosing mediastinitis (FM) is caused by proliferation of fibrous tissue in the mediastinum with encasement of mediastinal viscera and compression of mediastinal structures. Pulmonary hypertension (PH) is caused by extrinsic compression of the pulmonary arteries and/or veins.

We reviewed clinical, functional, hemodynamic, radiological characteristics and outcome of 27 consecutive cases of PH associated with FM diagnosed at the French Referral Centre for PH (2003-2014).

Right heart catheterization (RHC) confirmed PH in 14 men and 13 women. The causes of FM were sarcoidosis (n=13), tuberculosis-infection (n=9), mediastinal irradiation (n=2) and idiopathic (n=3). Sixteen patients were in NYHA functional class III and IV. RHC found moderate PH: median mean pulmonary artery pressure 42mmHg (27-90) and median cardiac index 2.8L/min/m2 (1.6-4.3). Severe extrinsic compression of pulmonary arteries was found in 2, 8 and 12 patients at the main, lobar or segmental level, respectively. 14 patients had at least one severe pulmonary venous compression. PAH therapy was initiated in 7 patients and corticosteroid therapy (0.5-1mg/kg/day) was initiated in 3 patients with sarcoidosis, 9 other being already on low dose corticosteroids. At 1 year follow-up, 3 were dead and among the 21 evaluated, 3 deteriorated, 14 were stable and 4 patients with sarcoidosis improved. Survival was 88%, 73% and 56% at 1, 3 and 5 years, respectively.

We found no clear clinical improvement with the use of specific PAH therapy. Corticosteroid therapy may be associated with clinical improvement, in some patients with FM due to sarcoidosis. Although never performed for this indication, lung transplantation may be proposed in eligible patients with severe PH and FM.

  • Pulmonary hypertension
  • Sarcoidosis
  • Interstitial lung disease
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Pulmonary hypertension complicating fibrosing mediastinitis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Pulmonary hypertension complicating fibrosing mediastinitis
Andrei Seferian, Alexandru Steriade, Xavier Jaïs, Olivier Planché, Laurent Savale, Florence Parent, David Amar, Roland Jovan, Elie Fadel, Olivier Sitbon, Gérald Simonneau, Marc Humbert, David Montani
European Respiratory Journal Sep 2016, 48 (suppl 60) OA261; DOI: 10.1183/13993003.congress-2016.OA261

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Pulmonary hypertension complicating fibrosing mediastinitis
Andrei Seferian, Alexandru Steriade, Xavier Jaïs, Olivier Planché, Laurent Savale, Florence Parent, David Amar, Roland Jovan, Elie Fadel, Olivier Sitbon, Gérald Simonneau, Marc Humbert, David Montani
European Respiratory Journal Sep 2016, 48 (suppl 60) OA261; DOI: 10.1183/13993003.congress-2016.OA261
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice
  • Antenatal sildenafil-simvastatin combination attenuates pulmonary hypoplasia and hypertension in nitrofen-induced congenital diaphragmatic hernia
  • Neutrophils' atomic force microscopy in COPD with pulmonary hypertension (PH)
Show more 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society